Thriving early environments boost brain and cognitive development in children

Researchers have found that environmental supports in the first year of life, termed the thrive factor (T-factor), play a crucial role in brain, cognitive, and socioemotional development in children by age 3, underscoring the importance of quality environments for early childhood development.

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Results of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show that adding an immunomodulatory agent to

September 1, 2023

Exclusive: Eli Lilly supplied schizophrenia drug to uncertified healthcare providers, Form 483 shows

Eli Lilly shipped its schizophrenia drug to uncertified pharmacies and was not adhering to established safety procedures, the FDA found after a September inspection at

January 31, 2024

FDA grants approval to Roche’s Tecentriq Hybreza for cancer

The FDA approval for Roche’s Tecentriq Hybreza was informed by data from the Phase IB/III IMscin001 trial. Credit: Marlon Trottmann/Shutterstock. The US Food and Drug

September 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.